Bank of America
RARX

Bank of America’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Bank of America’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-91,256
Closed -$4.38M – 7390
2020
Q1 		$4.38M Sell
91,256
-64,563
-41% -$3M ﹤0.01% 2783
2019
Q4 		$7.31M Buy
155,819
+2,386
+2% +$105K ﹤0.01% 2863
2019
Q3 		$3.63M Buy
153,433
+103,708
+209% +$3.07M ﹤0.01% 3511
2019
Q2 		$1.5M Sell
49,725
-88,330
-64% -$2.02M ﹤0.01% 4272
2019
Q1 		$3.09M Buy
138,055
+132,086
+2,213% +$2.84M ﹤0.01% 3619
2018
Q4 		$109K Sell
5,969
-56,420
-90% -$886K ﹤0.01% 5868
2018
Q3 		$1.13M Buy
62,389
+18,953
+44% +$225K ﹤0.01% 4395
2018
Q2 		$432K Buy
43,436
+36,352
+513% +$251K ﹤0.01% 4987
2018
Q1 		$38K Buy
7,084
+429
+6% +$3.07K ﹤0.01% 6154
2017
Q4 		$57K Buy
6,655
+4,240
+176% +$52.1K ﹤0.01% 6015
2017
Q3 		$35K Buy
2,415
+542
+29% +$8.19K ﹤0.01% 6091
2017
Q2 		$35K Buy
1,873
+420
+29% +$9.48K ﹤0.01% 6024
2017
Q1 		$31K Sell
1,453
-4,947
-77% -$94.6K ﹤0.01% 6131
2016
Q4 		$97K Buy
+6,400
New +$87K ﹤0.01% 5643

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Bank of America's RARX Position: Q2 2020 in Review

Bank of America sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 91,256 shares — an estimated $4.38M sold.

Bank of America first reported a position in RARX in Q4 2016 and held it in 14 quarters. The position peaked at $7.31M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • Bank of America reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Bank of America sold 91,256 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $4.38M.
  • Bank of America first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
  • Bank of America's Ra Pharmaceuticals, Inc. Common Stock position peaked at $7.31M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.